Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 18, 2013 - Issue 4
Submit an article Journal homepage
317
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Emerging antiangiogenics for renal cancer

Charlotte DomblidesBordeaux University Hospital, Hôpital Saint-André, Department of Medical Oncology, Bordeaux, France
,
Marine Gross-GoupilBordeaux University Hospital, Hôpital Saint-André, Department of Medical Oncology, Bordeaux, France
,
Amandine QuivyBordeaux University Hospital, Hôpital Saint-André, Department of Medical Oncology, Bordeaux, France;University of Bordeaux 2 (Victor Segalen), Bordeaux, France
&
Alain RavaudUniversity of Bordeaux 2 (Victor Segalen), Bordeaux, France;Bordeaux University Hospital, Hôpital Saint-André, Department of Medical Oncology, Bordeaux, France+33 556 79 58 08; +33 556 79 58 96; [email protected]
Pages 495-511 | Published online: 26 Nov 2013

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rima Ait-Belkacem, Caroline Berenguer, Claude Villard, L’Houcine Ouafik, Dominique Figarella-Branger, Alain Beck, Olivier Chinot & Daniel Lafitte. (2014) Monitoring therapeutic monoclonal antibodies in brain tumor. mAbs 6:6, pages 1385-1393.
Read now

Articles from other publishers (14)

Valentina Guadalupi, Giacomo Cartenì, Roberto Iacovelli, Camillo Porta, Giovanni Pappagallo, Riccardo Ricotta & Giuseppe Procopio. (2021) Second-line treatment in renal cell carcinoma: clinical experience and decision making. Therapeutic Advances in Urology 13, pages 175628722110228.
Crossref
David C. Yang & Ching-Hsien Chen. (2020) Potential New Therapeutic Approaches for Renal Cell Carcinoma. Seminars in Nephrology 40:1, pages 86-97.
Crossref
Nadire Özenver & Thomas Efferth. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer 357 387 .
Qiwei Yang, Ye Wang, Qing Yang, Yi Gao, Xiaopeng Duan, Qingcheng Fu, Chuanmin Chu, Xiuwu Pan, Xingang Cui & Yinghao Sun. (2017) Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer. Biomaterials 146, pages 72-85.
Crossref
Hiromi Sato, Miaki Uzu, Tatsuro Kashiba, Rina Suzuki, Takuya Fujiwara, Hiroko Okuzawa & Koichi Ueno. (2017) Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells. Oncology Letters 14:1, pages 937-943.
Crossref
Jiehui Di, Keyu Gao, Debao Qu, Yaoyao Wu, Jing Yang & Junnian Zheng. (2017) Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma. Tumor Biology 39:7, pages 101042831770165.
Crossref
C-H Chen, L W R Fong, E Yu, R Wu, J F Trott & R H Weiss. (2017) Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. Oncogene 36:25, pages 3588-3598.
Crossref
L Zhou, X-D Liu, M Sun, X Zhang, P German, S Bai, Z Ding, N Tannir, C G Wood, S F Matin, J A Karam, P Tamboli, K Sircar, P Rao, E B Rankin, D A Laird, A G Hoang, C L Walker, A J Giaccia & E Jonasch. (2015) Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene 35:21, pages 2687-2697.
Crossref
Menelaos Zafrakas, Panayiota Papasozomenou & Christos Emmanouilides. (2016) Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials. World Journal of Clinical Oncology 7:4, pages 331.
Crossref
Wendy K. Steagall, Connie G. Glasgow, Gustavo Pacheco-Rodriguez & Joel Moss. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR 397 415 .
Wenge Wang, Jihua Cheng, Carol Mallon, Mohammed Y. Al-Marrawi, Sheldon Holder, Monika Joshi, Matthew Kaag, Giampaolo Talamo & Joseph J. Drabick. (2015) Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review. Clinical Genitourinary Cancer 13:6, pages e391-e395.
Crossref
Angiolo Gadducci, Nora Lanfredini & Claudia Sergiampietri. (2015) Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research. Critical Reviews in Oncology/Hematology 96:1, pages 113-128.
Crossref
Nikolaus Krall, Francesca Pretto, Willy Decurtins, Gonçalo J. L. Bernardes, Claudiu T. Supuran & Dario Neri. (2014) A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors. Angewandte Chemie International Edition 53:16, pages 4231-4235.
Crossref
Nikolaus Krall, Francesca Pretto, Willy Decurtins, Gonçalo J. L. Bernardes, Claudiu T. Supuran & Dario Neri. (2014) Ein niedermolekulares Ligand‐Wirkstoff‐Konjugat zur Behandlung von Carboanhydrase IX exprimierenden Tumoren. Angewandte Chemie 126:16, pages 4315-4320.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.